Memorial Sloan Kettering Cancer Center Pancreas Cancer Symposium State-of-the-Art 2018

10 $

+ Include: 23 videos + 25 pdfs, size: 7.7 GB

+ Target Audience: medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists

Description

+ Include: 23 videos + 25 pdfs, size: 7.7 GB

+ Target Audience: medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists

+ Sample video: contact me for sample video

+ Information:

Date & Location

Friday, November 30, 2018, 7:30 AM – 5:30 PM EST, Zuckerman Research Center 417 E 68th St, New York, NY

Specialties
Specialties – Gastrointestinal Oncology, Genetics, Hospitalist, Internal Medicine, Medical Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pathology, Pharmacology and Medication Management, Physician Assistant, Solid Tumor Oncology, Surgical Oncology
Overview

Pancreas cancer incidence is on the rise. Treatment paradigms are changing and many novel approaches are under development in this disease. This one day course in conjunction with the Center for Pancreas Cancer Research at Memorial Sloan Kettering is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments under development and where the field is heading.

This course is designed for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, nursing, advanced practice practitioners, trainees and other disciplines

In partnership with the David M. Rubenstein Center for Pancreatic Cancer Research

Multidisciplinary Breakout Session | 10:50 am-12:30 pm

This session targets the following providers: Nurses, NP’s, PA’s, Clinical Trial Nurses, Social Workers and Nutritionists. Providers who practice in the Inpatient, Ambulatory Care setting, and clinical trials will benefit. Pancreas cancer presents with many challenges. Patients with pancreas cancer have a unique spectrum of disease and treatment related adverse events which often overlap making care of these patients challenging. Emerging clinical trials with new agents broaden the potential spectrum of toxicities. In this session a multidisciplinary team will address the complex care needs of these patients.

Objectives
  1. Understand the pathologic, genetic and molecular hallmarks of pancreas cancer
  2. Understand the importance of and where to optimally utilize multidisciplinary care for management of pancreas cancer
  3. Outline current diagnostic and surgical strategies for pancreas cancer
  4. Review the indications and implications of germline and somatic testing in pancreas cancer
  5. Define the key novel therapeutic approaches for management of pancreas cancer

 

+ Topics:

Adjuvant Neoadjuvant Therapy.mp4
Adjuvant Neoadjuvant Therapy.pdf
Advanced Endoscopy.mp4
Advanced Endoscopy.pdf
Balancing Hope and Fear- The Unique Challenge of Pancreatic Cancer.mp4
Balancing Hope and Fear- The Unique Challenge of Pancreatic Cancer.pdf
Challenges in Caring for the Pancreas Cancer Patient Participating in Clinical Trials.mp4
Challenges in Caring for the Pancreas Cancer Patient Participating in Clinical Trials.pdf
Clinical Genetics of Pancreas Cancer.mp4
Clinical Genetics of Pancreas Cancer.pdf
Emerging Research Directions in Supportive Oncology.pdf
Emerging Therapeutic Directions.mp4
Emerging Therapeutic Directions.pdf
Epidemiology of Pancreas Cancer.mp4
Epidemiology of Pancreas Cancer.pdf
Genetics of Pancreas Cancer.mp4
Genetics of Pancreas Cancer.pdf
Imaging, CT, PET and the Future.mp4
Imaging, CT, PET and the Future.pdf
Interactive Case.mp4
Interactive Case.pdf
Intraductal Papillary Mucinous Neoplasms- An Opportunity to Prevent Pancreatic Cancer.mp4
Intraductal Papillary Mucinous Neoplasms- An Opportunity to Prevent Pancreatic Cancer.pdf
Introduction.pdf
Molecular Tumor Board Cases.mp4
Molecular Tumor Board Cases.pdf
Novel Biomarkers for Pancreas Cancer.mp4
Novel Biomarkers for Pancreas Cancer.pdf
Novel Radiation Strategies for Pancreas Cancer.mp4
Novel Radiation Strategies for Pancreas Cancer.pdf
Novel Vaccine Strategies.mp4
Novel Vaccine Strategies.pdf
Nutrition and Pancreatic Cancer- Challenges and Choices.mp4
Nutrition and Pancreatic Cancer- Challenges and Choices.pdf
Pancreas Subtypes and More.mp4
Pancreas Subtypes and More.pdf
Pancreas_Cancer_2018_Brochure.pdf
QA and Panelist Discussion 2.mp4
QA and Panelist Discussion.mp4
Review and Management of Pancreas Cancer- Disease Symptoms and Side Effects of Standard of Care Treatments.mp4
Review and Management of Pancreas Cancer- Disease Symptoms and Side Effects of Standard of Care Treatments.pdf
Standard Therapies for Pancreas Cancer.mp4
Standard Therapies for Pancreas Cancer.pdf
Surgery for Pancreas Cancer.mp4
Surgery for Pancreas Cancer.pdf
Symposium Introduction & Welcome.pdf
Why are Ras and p53 Mutations the Most Common Molecular Signature in Pancreatic Cancer. New Insights to An Old Problem.mp4
Why are Ras and p53 Mutations the Most Common Molecular Signature in Pancreatic Cancer. New Insights to An Old Problem.pdf

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center Pancreas Cancer Symposium State-of-the-Art 2018”

Your email address will not be published. Required fields are marked *